Mesoblast Limited
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	6/30/2022	6/30/2023	6/30/2024	6/30/2026	6/30/2027	6/30/2028
Revenue % change YoY	$10.21M N/A	$7.50M -26.54%	$5.90M -21.31%	Avg: $46.3M Low: $44.80M High: $47.79M avg. 684.47%	Avg: $561.1M Low: $543M High: $579.2M avg. 1111.87%	Avg: $713.1M Low: $690.09M High: $736.10M avg. 27.08%
Net Income % change YoY	$-91.34M N/A	$-81.88M 10.35%	$-87.95M -7.40%	Avg: $-19.87M Low: $-20.70M High: $-19.04M avg. 77.40%	Avg: $239.29M Low: $229.25M High: $249.32M avg. 1303.92%	Avg: $317.23M Low: $303.93M High: $330.54M avg. 32.57%
EBITDA % change YoY	$-76.57M N/A	$-58.55M 23.53%	$-62.82M -7.29%	Avg: $-46.3M Low: $-47.79M High: $-44.80M avg. 26.30%	Avg: $-561.1M Low: $-579.2M High: $-543M avg. -1111.87%	Avg: $-713.1M Low: $-736.10M High: $-690.09M avg. -27.08%
EPS % change YoY	-$1.33 N/A	-$0.11 91.72%	-$0.09 19.00%	Avg: -$0.26 Low: -$0.27 High: -$0.24 avg. -186.19%	Avg: $3.07 Low: $2.94 High: $3.2 avg. 1303.92%	Avg: $4.07 Low: $3.9 High: $4.24 avg. 32.57%
Operating Expenses % change YoY	$90.78M N/A	$76.79M -15.41%	$63.87M -16.81%	Avg: $232.24M Low: $224.75M High: $239.73M avg. 263.59%	Avg: $2.81B Low: $2.72B High: $2.90B avg. 1111.87%	Avg: $3.57B Low: $3.46B High: $3.69B avg. 27.08%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 471.29% in 2026-2028.

We have gathered data from N/A analysts. Their low estimate is -20.70M, average is -19.87M and high is -19.04M.

Wall Street analysts forecast annual average revenue growth of 607.81% in 2026-2028.

We have gathered data from 1 analysts. Their low revenue estimate is $44.80M, average is $46.3M and high is $47.79M.

Wall Street analysts forecast annual average earnings growth of 383.43% in 2026-2028.

We have gathered data from N/A analysts. Their low earnings per share estimate is -$0.27, average is -$0.26 and high is $-0.24.